共 121 条
[1]
Przepiorka D(1999)Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation Biol Blood Marrow Transplant 5 94-97
[2]
Nash RA(2012)Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors Biol Blood Marrow Transplant 18 229-234
[3]
Wingard JR(2021)Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review Transplant Rev (Orlando) 35 100610-307
[4]
Zhu J(2019)Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report Ther Drug Monit 41 261-397
[5]
Maher RM(1982)A randomized study of the prevention of acute graft-versus-host disease N Engl J Med 306 392-768
[6]
Fitzsimmons WE(1999)Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation Bone Marrow Transplant 24 763-348
[7]
Mori T(2005)Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 36 343-577
[8]
Kato J(2008)Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children Bone Marrow Transplant 41 571-163
[9]
Shimizu T(2011)Treatment of chronic graft-versus-host disease: Past, present and future Korean J Hematol 46 153-1137
[10]
Aisa Y(2014)Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy Int J Clin Pharm 36 1134-2162